Patents by Inventor Santosh Sadashiv Chothe

Santosh Sadashiv Chothe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8865213
    Abstract: Disclosed herein are multiparticulate modified release pharmaceutical compositions comprising: (a) a first portion comprising an active ingredient, at least one surfactant and at least one release modifying agent and (b) a second portion comprising an active ingredient and optionally a release modifying agent. Particularly, the active ingredient in the first portion is a calcium channel blocker and the modified release composition is in the form of a multiparticulate tablet.
    Type: Grant
    Filed: December 29, 2010
    Date of Patent: October 21, 2014
    Assignees: USV Limited, Indicus Pharma LLC
    Inventors: Nitin Vadilal Sheth, Sunil Suresh Jog, Santosh Sadashiv Chothe, Sampada Hemant Tupe
  • Publication number: 20110159093
    Abstract: Disclosed herein are multiparticulate modified release pharmaceutical compositions comprising: (a) a first portion comprising an active ingredient, at least one surfactant and at least one release modifying agent and (b) a second portion comprising an active ingredient and optionally a release modifying agent. Particularly, the active ingredient in the first portion is a calcium channel blocker and the modified release composition is in the form of a multiparticulate tablet.
    Type: Application
    Filed: December 29, 2010
    Publication date: June 30, 2011
    Applicants: USV Limited, Indicus Pharma LLC
    Inventors: Nitin Vadilal Sheth, Sunil Suresh Jog, Santosh Sadashiv Chothe, Sampada Hemant Tupe
  • Publication number: 20100086590
    Abstract: The present invention discloses novel stable oral pharmaceutical compositions comprising the active ingredient Clopidogrel bisulfate and hydrophilic polymers along with pharmaceutically acceptable excipients. Particularly, the said Clopidogrel bisulfate is crystalline Form 1 and the composition additionally comprises of one or more chelating agents and antioxidants. Further the invention relates to a novel process for preparation of stable pharmaceutical compositions wherein the Clopidogrel bisulfate Form I is coated with a hydrophilic polymer thereby providing an increased physical and chemical stability to the composition.
    Type: Application
    Filed: October 8, 2009
    Publication date: April 8, 2010
    Applicant: USV Limited
    Inventors: Deepak Anant Hegde, Santosh Sadashiv Chothe, Imran Shakur Ghogari, Ashok Omray